Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis

Darius Gleiznys; Albertas Kriauciunas; Julius Maminskas; Arturas Stumbras; Dalia Giedrimiene; Christine Niekrash; Alvydas Gleiznys; Jurgina Sakalauskiene; Astra Vitkauskiene

doi:10.12659/MSM.932243

26 October 2021 : Clinical Research

Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis

Darius Gleiznys^1ABCDEFG*, Albertas Kriauciunas^1BCDE, Julius Maminskas^1AB, Arturas Stumbras^2FG, Dalia Giedrimiene^3CD, Christine Niekrash^4CDE, Alvydas Gleiznys^5AD, Jurgina Sakalauskiene^1ABEF, Astra Vitkauskiene^6ACDE

DOI: 10.12659/MSM.932243

Med Sci Monit 2021; 27:e932243

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 1 Clinical data of patients with healthy implants (HP) and peri-implant mucositis patients (MP).

Mean (SD)	HP, n=30	MP, n=30	P value
Age, years	63.1 (1.7)	63.0 (2.0)	>0.05
Probing depth, mm	1.4 (0.2)	3.0 (0.2)	<0.001
Plaque index	0	0.53 (0.31)	<0.001
Marginal bleeding index	0	0.26 (0.07)	<0.001
SD – standard deviation; value by test.

Back to the Article

Expression of Interleukin-17, Tumor Necrosis Factor-Alpha, and Matrix Metalloproteinase-8 in Patients with Chronic Peri-Implant Mucositis

Your Privacy